These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 3524923)
21. Idiopathic membranous glomerulonephritis: a clinicopathologic and quantitative morphometric study. Toth T; Takebayashi S Clin Nephrol; 1992 Jul; 38(1):14-9. PubMed ID: 1499164 [TBL] [Abstract][Full Text] [Related]
22. A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy. Jha V; Ganguli A; Saha TK; Kohli HS; Sud K; Gupta KL; Joshi K; Sakhuja V J Am Soc Nephrol; 2007 Jun; 18(6):1899-904. PubMed ID: 17494881 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of efficacy of methylprednisolone, prednisolone and chlorambucil in idiopathic glomerulonephritis. Nand N; Das R; Jaswal TS J Indian Med Assoc; 1997 Jun; 95(6):163-5, 174. PubMed ID: 9420390 [TBL] [Abstract][Full Text] [Related]
24. Cyclosporin A treatment for idiopathic membranous nephropathy. Yao X; Chen H; Wang Q; Tang Z; Hu W; Yin G; Liu Z; Li L Chin Med J (Engl); 2001 Dec; 114(12):1305-8. PubMed ID: 11793859 [TBL] [Abstract][Full Text] [Related]
25. Treatment-related changes in urinary excretion of high and low molecular weight proteins in patients with idiopathic membranous nephropathy and renal insufficiency. du Buf-Vereijken PW; Wetzels JF Nephrol Dial Transplant; 2006 Feb; 21(2):389-96. PubMed ID: 16234291 [TBL] [Abstract][Full Text] [Related]
27. Methylprednisolone in patients with membranous nephropathy and declining renal function. Short CD; Solomon LR; Gokal R; Mallick NP Q J Med; 1987 Nov; 65(247):929-40. PubMed ID: 3455548 [TBL] [Abstract][Full Text] [Related]
28. Corticosteroid therapy in IgA nephropathy with nephrotic syndrome: a long-term controlled trial. Lai KN; Lai FM; Ho CP; Chan KW Clin Nephrol; 1986 Oct; 26(4):174-80. PubMed ID: 3536231 [TBL] [Abstract][Full Text] [Related]
29. Long-term outcome of patients with idiopathic membranous nephropathy. Ríhová Z; Merta M; Maixnerová D; Honsová E; Reiterová J; Rysavá R; Zabka J; Tesar V Prague Med Rep; 2006; 107(2):189-98. PubMed ID: 17066739 [TBL] [Abstract][Full Text] [Related]
30. Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions. Faedda R; Pirisi M; Satta A; Tanda F; Bartoli E Clin Nephrol; 1996 Oct; 46(4):237-44. PubMed ID: 8905208 [TBL] [Abstract][Full Text] [Related]
34. The clinical course of idiopathic membranous nephropathy. Erwin DT; Donadio JV; Holley KE Mayo Clin Proc; 1973 Oct; 48(10):697-712. PubMed ID: 4745542 [No Abstract] [Full Text] [Related]
35. Evolution of membranous nephropathy from a proliferative and exudative glomerulonephritis--a report of three cases studied by serial biopsies. Kapur S; Salcedo J; Chandra R; Antonovych T Int J Pediatr Nephrol; 1985; 6(2):105-10. PubMed ID: 3897088 [TBL] [Abstract][Full Text] [Related]
36. Resolution of diffuse membranous changes with remission of nephrotic syndrome. Osawa G; Kinoshita Y; Morita T; Soda T; Wada J Tohoku J Exp Med; 1976 Oct; 120(2):177-90. PubMed ID: 982435 [TBL] [Abstract][Full Text] [Related]
37. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome. Alexopoulos E; Papagianni A; Tsamelashvili M; Leontsini M; Memmos D Nephrol Dial Transplant; 2006 Nov; 21(11):3127-32. PubMed ID: 16968719 [TBL] [Abstract][Full Text] [Related]
38. Efficacy of steroids, cyclosporin and cyclophos-phamide in steroid resistant idiopathic nephrotic syndrome. Hafeez F; Ahmad TM; Anwar S J Coll Physicians Surg Pak; 2005 Jun; 15(6):329-32. PubMed ID: 15924835 [TBL] [Abstract][Full Text] [Related]
39. Long-term outcomes of idiopathic membranous nephropathy in Japanese patients treated with low-dose cyclophosphamide and prednisolone. Eriguchi M; Oka H; Mizobuchi T; Kamimura T; Sugawara K; Harada A Nephrol Dial Transplant; 2009 Oct; 24(10):3082-8. PubMed ID: 19465558 [TBL] [Abstract][Full Text] [Related]